Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / American Depository Shares
-
Shares outstanding
-
1,786,081
-
Total 13F shares
-
536,161
-
Share change
-
+44,100
-
Total reported value
-
$4,344,316
-
Put/Call ratio
-
65%
-
Price per share
-
$9.87
-
Number of holders
-
12
-
Value change
-
+$396,634
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) as of Q2 2021
As of 30 Jun 2021,
KAZIA THERAPEUTICS LTD - American Depository Shares (KZIA) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
536,161 shares.
The largest 10 holders included
MORGAN STANLEY, Transform Wealth, LLC, RENAISSANCE TECHNOLOGIES LLC, SG Americas Securities, LLC, TRUIST FINANCIAL CORP, ACT Capital Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, SIMPLEX TRADING, LLC, and Steward Partners Investment Advisory, LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.